Abstract:Double‐stranded DNA nanostructures fully inhibit amyloid fibril formation and efficiently disassemble enzymatically and thermodynamically stable fibrils into cytocompatible and degradable complexes. Remarkably, DNA nanostructures avidly trap highly toxic soluble oligomeric species in complex biological media and convert them into non‐toxic binary complexes. The deposition of insoluble proteinaceous aggregates in the form of amyloid fibrils within the extracellular space of tissues is associated with numerous diseases. The development of molecular approaches to arrest amyloid formation and prevent cellular degeneration remains very challenging due to the complexity of the process of protein aggregation, which encompasses an infinite array of conformations and quaternary structures. Polyanionic biopolymers, such as glycosaminoglycans and RNAs, have been shown to modulate the self‐assembly of amyloidogenic polypeptides and to reduce the toxicity induced by the formation of oligomeric and/or pre‐fibrillar proteospecies. This study evaluates the effects of double‐stranded DNA (dsDNA) nanostructures (1D, 2D, and 3D) on amyloid self‐assembly, fibril disaggregation, and the cytotoxicity associated with amyloidogenesis. Using the islet amyloid polypeptide (IAPP) whose pancreatic accumulation is the hallmark of type 2 diabetes, it was observed that dsDNA nanostructures inhibit amyloid formation by inducing the formation of spherical complexes in which the peptide adopts a random coil conformation. Interestingly, the DNA nanostructures showed a persistent ability to disassemble enzymatically and thermodynamically stable amyloid fibrils into nanoscale DNA/IAPP entities that are fully compatible with β‐pancreatic cells and are biodegradable by proteolysis. Notably, dsDNA nanostructures avidly trapped highly toxic soluble oligomeric species in complete cell culture media and converted them into non‐toxic binary complexes. Overall, these results expose the potent modulatory effects of dsDNA on amyloidogenic pathways, and these DNA nanoscaffolds could be used as a source of inspiration for the design of molecules to fight amyloid‐related disorders.

Supramolecular Glycosylation Accelerates Proteolytic Degradation of Peptide Nanofibrils

Synergistic Inhibitory Effect of Peptide-Organic Coassemblies on Amyloid Aggregation.

A Peptide N-Terminal Protection Strategy For Comprehensive Glycoproteome Analysis Using Hydrazide Chemistry Based Method

Design, Synthesis and Biological Evaluation of α-Synuclein Proteolysis-Targeting Chimeras

Molecular Dynamics Simulations on the Oligomer-Formation Process of the GNNQQNY Peptide from Yeast Prion Protein Sup35.

Oligomerization of Yeast Prion Sup35NM

O-Glycosylation Induces Amyloid-β To Form New Fibril Polymorphs Vulnerable for Degradation

Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly

Supramolecular Senolytics via Intracellular Oligomerization of Peptides in Response to Elevated Reactive Oxygen Species Levels in Aging Cells.

Exploring Peptido-Nanocomposites in the Context of Amyloid Diseases

Quantitative Study of the Oligomerization of Yeast Prion Sup35NM Proteins.

Cooperative dissolution of peptidomimetic vesicles and amyloid beta fibrils

Targeting the Amyloid-β Fibril Surface with a Constrained Helical Peptide Inhibitor.

N-Linked Glycosylation Prevents Deamidation of Glycopeptide and Glycoprotein

Hybrid Peptides Attenuate Cytotoxicity of Β-Amyloid by Inhibiting Its Oligomerization: Implication from Solvent Effects

Introducing D-amino acid or simple glycoside into small peptides to enable supramolecular hydrogelators to resist proteolysis.

DNA nanostructures prevent the formation of and convert toxic amyloid proteospecies into cytocompatible and biodegradable spherical complexes

Peptides for Disrupting and Degrading Amyloids.

Turning the structure of the A beta(42) peptide by different functionalized carbon nanotubes: a molecular dynamics simulation study

O-GlcNAcylation Inhibits the Oligomerization of Alpha-Synuclein by Declining Intermolecular Hydrogen Bonds Through a Steric Effect.

Stabilizing Amyloid-Β Peptide by the N-terminus Capture is Capable of Preventing and Eliminating Amyloid-Β Oligomers.